{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:34:46Z","timestamp":1772120086874,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"DOI":"10.1007\/s12687-024-00739-2","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T07:01:46Z","timestamp":1728630106000},"page":"673-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Knowledge, attitude and acceptance regarding bone marrow transplantation in caregivers of beta-thalassemia major patients"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4642-020X","authenticated-orcid":false,"given":"Purva Reddy","family":"Jayaram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahana","family":"Devadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5991-4316","authenticated-orcid":false,"given":"Paridhi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayathri","family":"Devi C","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"issue":"11","key":"739_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jtct.2023.07.014","volume":"29","author":"RK Agarwal","year":"2023","unstructured":"Agarwal RK, Dhanya R, Sedai A et al (2023) Bone Marrow Quality Index: a predictor of Acute Graft-versus-host disease in hematopoietic stem cell transplantation for Thalassemia. Transplantation Cell Therapy 29(11):711.e1-711.e6. https:\/\/doi.org\/10.1016\/j.jtct.2023.07.014","journal-title":"Transplantation Cell Therapy"},{"key":"739_CR5","doi-asserted-by":"publisher","unstructured":"Ali S, Mumtaz S, Shakir HA et al (2021) Current status of beta-thalassemia and its treatment strategies. Mol Genet Genom Med 9(12). https:\/\/doi.org\/10.1002\/mgg3.1788","DOI":"10.1002\/mgg3.1788"},{"issue":"6","key":"739_CR20","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbmt.2020.01.002","volume":"26","author":"U Anurathapan","year":"2020","unstructured":"Anurathapan U, Hongeng S, Pakakasama S et al (2020) Hematopoietic stem cell transplantation for severe thalassemia patients from Haploidentical Donors using a Novel Conditioning Regimen. Biol Blood Marrow Transpl 26(6):1106\u20131112. https:\/\/doi.org\/10.1016\/j.bbmt.2020.01.002","journal-title":"Biol Blood Marrow Transpl"},{"key":"739_CR7","doi-asserted-by":"publisher","unstructured":"Anurogo D, Yuli Prasetyo Budi N, Thi Ngo MH, Huang YH, Pawitan JA (2021) Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. Int J Mol Sci. ;22(12):6275. Published 2021 Jun 10. https:\/\/doi.org\/10.3390\/ijms22126275","DOI":"10.3390\/ijms22126275"},{"issue":"2","key":"739_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1182\/bloodadvances.2020002948","volume":"5","author":"SM Badawy","year":"2021","unstructured":"Badawy SM, Beg U, Liem RI, Chaudhury S, Thompson AA (2021) A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy. Blood Adv 5(2):570\u2013583. https:\/\/doi.org\/10.1182\/bloodadvances.2020002948","journal-title":"Blood Adv"},{"issue":"4","key":"739_CR18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/bmt.2015.293","volume":"51","author":"D Baronciani","year":"2016","unstructured":"Baronciani D, Angelucci E, Potschger U et al (2016) Hemopoietic stem cell transplantation in Thalassemia: a report from the European Society for Blood and bone marrow transplantation Hemoglobinopathy Registry, 2000\u20132010. Bone Marrow Transpl 51(4):536\u2013541. https:\/\/doi.org\/10.1038\/bmt.2015.293","journal-title":"Bone Marrow Transpl"},{"key":"739_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.omtm.2020.03.015","volume":"17","author":"C Brendel","year":"2020","unstructured":"Brendel C, Negre O, Rothe M et al (2020) Preclinical evaluation of a Novel Lentiviral Vector driving lineage-specific BCL11A knockdown for Sickle Cell Gene Therapy. Mol Ther Methods Clin Dev 17:589\u2013600 Published 2020 Mar 17. https:\/\/doi.org\/10.1016\/j.omtm.2020.03.015","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"739_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61\u201376. https:\/\/doi.org\/10.1097\/GIM.0b013e3181cd68ed","journal-title":"Genet Med"},{"key":"739_CR13","unstructured":"Crisponi G, Nurchi VM, Lachowicz JI (2019) Iron Chelation for Iron overload in Thalassemia. Met Ions Life Sci 19. :\/books\/9783110527872\/9783110527872-009\/9783110527872-009.xml"},{"issue":"4","key":"739_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/03630269.2016.1190373","volume":"40","author":"H Darvishi Khezri","year":"2016","unstructured":"Darvishi Khezri H, Emami Zeydi A, Sharifi H, Jalali H (2016) Is vitamin C supplementation in patients with \u03b2-Thalassemia Major Beneficial or detrimental? Hemoglobin 40(4):293\u2013294. https:\/\/doi.org\/10.1080\/03630269.2016.1190373","journal-title":"Hemoglobin"},{"issue":"7","key":"739_CR27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1182\/bloodadvances.2019000760]","volume":"4","author":"R Dhanya","year":"2020","unstructured":"Dhanya R, Sedai A, Ankita K et al (2020) Life expectancy and risk factors for early death in patients with severe thalassemia syndromes in South India. Blood Adv 4(7):1448\u20131457. https:\/\/doi.org\/10.1182\/bloodadvances.2019000760]","journal-title":"Blood Adv"},{"issue":"4","key":"739_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tracli.2018.07.006","volume":"25","author":"O Garraud","year":"2018","unstructured":"Garraud O, Cognasse F, Laradi S et al (2018) How to mitigate the risk of inducing transfusion-associated adverse reactions. Transfus Clin Biol 25(4):262\u2013268. https:\/\/doi.org\/10.1016\/j.tracli.2018.07.006","journal-title":"Transfus Clin Biol"},{"key":"739_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1345.024","volume":"1054","author":"J Gaziev","year":"2005","unstructured":"Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G (2005) Bone marrow transplantation in adults with thalassemia: treatment and long-term follow-up. Ann N Y Acad Sci 1054:196\u2013205. https:\/\/doi.org\/10.1196\/annals.1345.024","journal-title":"Ann N Y Acad Sci"},{"key":"739_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.med.46.1.319","volume":"46","author":"C Giardini","year":"1995","unstructured":"Giardini C, Galimberti M, Lucarelli G (1995) Bone marrow transplantation in Thalassemia. Annu Rev Med 46:319\u2013330. https:\/\/doi.org\/10.1146\/annurev.med.46.1.319","journal-title":"Annu Rev Med"},{"issue":"5","key":"739_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/03630269.2023.2269846","volume":"47","author":"A Grewal","year":"2023","unstructured":"Grewal A, Kakkar S, Dewan P, Bansal N, Sobti PC, Eleftheriou P (2023) Prevalence, severity, and determinants of Pain in Thalassemia. Hemoglobin 47(5):191\u2013197. https:\/\/doi.org\/10.1080\/03630269.2023.2269846","journal-title":"Hemoglobin"},{"issue":"2","key":"739_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40291-024-00696-z","volume":"28","author":"SM Hoy","year":"2024","unstructured":"Hoy SM (2024) Exagamglogene Autotemcel: first approval. Mol Diagn Ther 28(2):133\u2013139. https:\/\/doi.org\/10.1007\/s40291-024-00696-z","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"739_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.hoc.2022.12.013","volume":"37","author":"JL Kwiatkowski","year":"2023","unstructured":"Kwiatkowski JL (2023) Clinical challenges with Iron Chelation in Beta Thalassemia. Hematol Oncol Clin North Am 37(2):379\u2013391. https:\/\/doi.org\/10.1016\/j.hoc.2022.12.013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"13","key":"739_CR28","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1182\/blood-2013-05-502658","volume":"122","author":"G La Nasa","year":"2013","unstructured":"La Nasa G, Caocci G, Efficace F et al (2013) Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. Blood 122(13):2262\u20132270. https:\/\/doi.org\/10.1182\/blood-2013-05-502658","journal-title":"Blood"},{"issue":"6","key":"739_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/biology10060546","volume":"10","author":"A Makis","year":"2021","unstructured":"Makis A, Voskaridou E, Papassotiriou I, Hatzimichael E (2021) Novel therapeutic advances in \u03b2-Thalassemia. Biology (Basel) 10(6):546 Published 2021 Jun 18. https:\/\/doi.org\/10.3390\/biology10060546","journal-title":"Biology (Basel)"},{"key":"739_CR4","unstructured":"Mayo Clinic (2021) Thalassemia - symptoms and causes. Mayo Clin Published November 17, https:\/\/www.mayoclinic.org\/diseases-conditions\/thalassemia\/symptoms-causes\/syc-20354995"},{"issue":"11","key":"739_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40265-020-01341-9","volume":"80","author":"I Motta","year":"2020","unstructured":"Motta I, Bou-Fakhredin R, Taher AT, Cappellini MD (2020) Beta thalassemia: New Therapeutic options Beyond Transfusion and Iron Chelation. Drugs 80(11):1053\u20131063. https:\/\/doi.org\/10.1007\/s40265-020-01341-9","journal-title":"Drugs"},{"issue":"1","key":"739_CR9","first-page":"30","volume":"102","author":"JS Raval","year":"2020","unstructured":"Raval JS, Griggs JR, Fleg A (2020) Blood product transfusion in adults: indications, adverse reactions, and modifications. Am Fam Physician 102(1):30\u201338","journal-title":"Am Fam Physician"},{"issue":"17","key":"739_CR8","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood-2018-10-860809","volume":"133","author":"JW Semple","year":"2019","unstructured":"Semple JW, Rebetz J, Kapur R (2019) Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood 133(17):1840\u20131853. https:\/\/doi.org\/10.1182\/blood-2018-10-860809","journal-title":"Blood"},{"issue":"4","key":"739_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s1473-3099(06)70437-6","volume":"6","author":"S Vento","year":"2006","unstructured":"Vento S, Cainelli F, Cesario F (2006) Infections and thalassaemia. Lancet Infect Dis 6(4):226\u2013233. https:\/\/doi.org\/10.1016\/s1473-3099(06)70437-6","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"739_CR23","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s10815-019-01595-7","volume":"36","author":"J Wang","year":"2019","unstructured":"Wang J, Lu BM, Li R et al (2019) Karyomapping in preimplantation genetic testing for \u03b2-thalassemia combined with HLA matching: a systematic summary. J Assist Reprod Genet 36(12):2515\u20132523. https:\/\/doi.org\/10.1007\/s10815-019-01595-7","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"739_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13287-020-01765-w","volume":"11","author":"Y Xian","year":"2020","unstructured":"Xian Y, Xie Y, Song B et al (2020) The safety and effectiveness of genetically corrected iPSCs derived from \u03b2-thalassaemia patients in nonmyeloablative \u03b2-thalassaemic mice. Stem Cell Res Ther 11(1):288. https:\/\/doi.org\/10.1186\/s13287-020-01765-w. Published 2020 Jul 16","journal-title":"Stem Cell Res Ther"},{"key":"739_CR3","doi-asserted-by":"publisher","unstructured":"Yadav SS, Panchal P, Menon KC (2022) Prevalence and Management of \u03b2-Thalassemia in India. Hemoglobin. Published online February 7, :1\u20136. https:\/\/doi.org\/10.1080\/03630269.2021.2001346","DOI":"10.1080\/03630269.2021.2001346"},{"issue":"8","key":"739_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.braindev.2006.02.005","volume":"28","author":"DI Zafeiriou","year":"2006","unstructured":"Zafeiriou DI, Economou M, Athanasiou-Metaxa M (2006) Neurological complications in \u03b2-thalassemia. Brain Develop 28(8):477\u2013481. https:\/\/doi.org\/10.1016\/j.braindev.2006.02.005","journal-title":"Brain Develop"},{"issue":"12","key":"739_CR21","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00439-023-02610-9","volume":"142","author":"S Zeng","year":"2023","unstructured":"Zeng S, Lei S, Qu C, Wang Y, Teng S, Huang P (2023) CRISPR\/Cas-based gene editing in therapeutic strategies for beta-thalassemia. Hum Genet 142(12):1677\u20131703. https:\/\/doi.org\/10.1007\/s00439-023-02610-9","journal-title":"Hum Genet"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-024-00739-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-024-00739-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-024-00739-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T06:30:45Z","timestamp":1734071445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-024-00739-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s12687-024-00739-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5020338\/v1","asserted-by":"object"}]},"ISSN":["1868-6001"],"issn-type":[{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained. Approved by IEC- BMCRI- No: BMCRI\/EC.05\/23-24","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Purva Reddy Jayaram, Dr. Sahana Devadas, Paridhi Jain, Dr. Gayathri Devi C declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}